Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.
4.

A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.

Katelaris CH, Ciprandi G, Missotten L, Turner FD, Bertin D, Berdeaux G; International Olopatadine Study Group.

Clin Ther. 2002 Oct;24(10):1561-75.

PMID:
12462286
6.

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis.

Abelson MB, Gomes PJ, Pasquine T, Edwards MR, Gross RD, Robertson SM.

Allergy Asthma Proc. 2007 Jul-Aug;28(4):427-33.

PMID:
17883910
7.

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.

Lanier BQ, Finegold I, D'Arienzo P, Granet D, Epstein AB, Ledgerwood GL.

Curr Med Res Opin. 2004 Aug;20(8):1227-33.

PMID:
15324525
8.

Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.

Mah FS, Rosenwasser LJ, Townsend WD, Greiner JV, Bensch G.

Curr Med Res Opin. 2007 Jun;23(6):1445-52. Epub 2007 May 18.

PMID:
17559743
14.

Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.

Fujishima H, Ohashi Y, Takamura E.

Ann Allergy Asthma Immunol. 2014 Oct;113(4):476-81. doi: 10.1016/j.anai.2014.07.007. Epub 2014 Aug 20.

PMID:
25163405
17.
18.

Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.

Gong L, Sun X, Qu J, Wang L, Zhang M, Zhang H, Wang L, Gu Y, Elion-Mboussa A, Roy L, Zhu B.

Clin Ther. 2012 Jun;34(6):1259-1272.e1. doi: 10.1016/j.clinthera.2012.04.024. Epub 2012 May 23.

PMID:
22627057
19.

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.

Mah FS, O'Brien T, Kim T, Torkildsen G.

Curr Med Res Opin. 2008 Feb;24(2):441-7. doi: 10.1185/030079908X261078 .

PMID:
18167176
Items per page

Supplemental Content

Write to the Help Desk